(Reuters) -Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in ... late-stage ...

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

New weight loss drug target reduces appetite and burns calories without sickness - The discovery could lead to a new ...

Early studies show a drug can effectively 'switch on' particular cells within the nervous system that play an important role ...

Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's ...

Analysts cited data from a phase one study showing the highest dose of Amgen’s MariTide was linked to roughly 4% loss of bone ...

Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone mineral density, a ...

A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the ...

Cantor analysts said they found the bone mineral density changes when reviewing supplemental data that was published along ...

While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...

Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results ...